Building the future of respiratory care
Be part of the journey to uncover new insights into respiratory health and create better outcomes for patients everywhere.
Learn more
Your Participation Makes a Difference
By joining our clinical studies, you will play a vital role in advancing respiratory health by:
Contributing to meaningful research to improve respiratory diagnosis and treatment.
Supporting better outcomes for respiratory patients.
Helping develop personalized treatment technologies.
Your safety is our top priority, and participation is completely voluntary; you can withdraw at any time without any penalty.
We value your contribution, and we will ensure your time and effort are acknowledged with financial reimbursement in accordance with ethical research guidelines.
Together, we can pave the way for more accurate diagnoses and effective therapies.
Our clinical studies
ENBOARD - Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity
Melbourne, Australia
ENBOARD aims to investigate the relationship between nasal molecular biomarkers and disease severity in individuals with chronic respiratory conditions, such as asthma, chronic sinusitis, and COPD, as well as in healthy controls. The study focuses on developing non-invasive diagnostic tools by identifying and validating nasal biomarkers that can provide objective insights into disease progression and treatment efficacy.
Criteria
250 participants needed.
Healthy volunteers: Individuals with no history of respiratory disorders.
Participants with chronic respiratory conditions including asthma, chronic sinusitis and COPD (especially active or moderate/severe disease).
What's involved:
A single 1-2hr site visit in Notting Hill, Melbourne
Involves specimen collection and respiratory testing
This is an observational study only, no drugs will be administered
NSCER - Nasal Sampling for Clinical Evaluation and Research
Pennsylvania, United States
NSCER was designed to evaluate the potential of nasal fluid biomarkers for respiratory health assessment and disease monitoring. The study aimed to establish baseline biomarker profiles in healthy individuals and compare them with profiles from participants with a history of nasal diseases, including chronic rhinosinusitis and other conditions providing valuable insights into disease mechanisms and diagnostic opportunities.
General questions
These studies aim to advance non-invasive diagnostic tools, improving how respiratory diseases are detected, monitored, and managed.
Healthy individuals and those with conditions like asthma, chronic sinusitis, or COPD.
Nasal biomarkers are biological molecules in nasal fluid that can provide insights into respiratory health and disease.
By uncovering biomarkers, they enable the development of precision diagnostics and personalized treatments for respiratory diseases.
Participation questions
Provide nasal, blood, or saliva samples, answer health-related questions, and potentially undergo additional tests.
Study duration varies, but most visits are brief at around 1 hour.
Yes, participation typically involves visiting a designated clinic or research centre for sample collection.
Yes, these studies offer compensation for time and travel; details will be shared during the consent process.
You will not be able to participate, but the team may guide you to other research opportunities.
Join our mission to eliminate respiratory disease
Reach out today to learn how you can help make a difference.
Get in touch